Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Epidermolysis Bullosa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05062070
What this trial is testing

Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis Bullosa Simplex
BioMendics, LLC 6
Early research (Phase 1)Study completedNCT00014729
What this trial is testing

Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
University of North Carolina 20
Not applicableStudy completedNCT04217538
What this trial is testing

Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Centre Hospitalier Universitaire de Nice 41
Testing effectiveness (Phase 2)Study completedNCT05651607
What this trial is testing

Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa

Who this might be right for
Hereditary Epidermolysis Bullosa
Assistance Publique - Hôpitaux de Paris 10
Very early researchLooking for participantsNCT05649098
What this trial is testing

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

Who this might be right for
Skin Diseases
Northwestern University 30
Early research (Phase 1)Study completedNCT02793960
What this trial is testing

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Shasa Hu 11
Large-scale testing (Phase 3)Study completedNCT04227106
What this trial is testing

Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 11
Testing effectiveness (Phase 2)Study completedNCT00004359
What this trial is testing

Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita

Who this might be right for
Epidermolysis Bullosa Acquisita
National Center for Research Resources (NCRR) 10
Testing effectiveness (Phase 2)Ended earlyNCT00311766
What this trial is testing

Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
RegeneRx Biopharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01263379
What this trial is testing

Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Abeona Therapeutics, Inc 12
Large-scale testing (Phase 3)Ended earlyNCT00587223
What this trial is testing

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica
Organogenesis 1
Testing effectiveness (Phase 2)Study completedNCT01294241
What this trial is testing

Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)

Who this might be right for
Inherited Epidermolysis Bullosa
Birken AG 10
Not applicableActive Not RecruitingNCT05843994
What this trial is testing

Artificial Intelligence Patient App for RDEB SCCs

Who this might be right for
Epidermolysis Bullosa Dystrophica
Northwestern University 20
Early research (Phase 1)Study completedNCT03472287
What this trial is testing

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa SimplexDystrophic Epidermolysis Bullosa+1 more
Castle Creek Pharmaceuticals, LLC 11
Testing effectiveness (Phase 2)Study completedNCT00951964
What this trial is testing

Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)

Who this might be right for
Epidermolysis Bullosa Dystrophica
Centre Hospitalier Universitaire de Nice 18
Testing effectiveness (Phase 2)Ended earlyNCT02984085
What this trial is testing

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Holostem s.r.l. 3
Testing effectiveness (Phase 2)Study completedNCT04599881
What this trial is testing

PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Phoenix Tissue Repair, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT07193134
What this trial is testing

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Who this might be right for
RDEBRecessive Dystrophic Epidermolysis BullosaEpidermolysis Bullosa Dystrophica, Recessive
CHU de Quebec-Universite Laval 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04186650
What this trial is testing

Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Institut National de la Santé Et de la Recherche Médicale, France 3
Testing effectiveness (Phase 2)Study completedNCT03836001
What this trial is testing

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Stanford University 28
Next Page